{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:58:05Z","timestamp":1774684685705,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.anl.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T08:16:53Z","timestamp":1504253813000},"page":"637-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cetuximab with radiotherapy as an alternative treatment for advanced squamous cell carcinoma of the temporal bone"],"prefix":"10.1016","volume":"45","author":[{"given":"Koji","family":"Ebisumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Okami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukuko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2017.08.005_bib0005","first-page":"665","article-title":"Predictors of survival and recurrence after temporal bone resection for cancer","volume":"32","author":"Morris","year":"2012","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.anl.2017.08.005_bib0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/MAO.0b013e318210b90f","article-title":"Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone","volume":"32","author":"Chi","year":"2011","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.anl.2017.08.005_bib0015","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/MAO.0b013e318281e0a9","article-title":"Guidelines for treating temporal bone carcinoma based on long-term outcomes","volume":"34","author":"Bacciu","year":"2013","journal-title":"Otol Neurotol"},{"issue":"Suppl. 1","key":"10.1016\/j.anl.2017.08.005_bib0020","first-page":"E949","article-title":"Concomitant chemoradiotherapy for advanced squamous cell carcinoma of the temporal bone","volume":"38","author":"Shinomiya","year":"2016","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.anl.2017.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ijrobp.2007.01.052","article-title":"Treatment and prognosis of squamous cell carcinoma of the external auditory canal and middle ear: a multi-institutional retrospective review of 87 patients","volume":"68","author":"Ogawa","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anl.2017.08.005_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0031-1275244","article-title":"Concomitant chemoradiotherapy as a standard treatment for squamous cell carcinoma of the temporal bone","volume":"21","author":"Shiga","year":"2011","journal-title":"Skull Base"},{"key":"10.1016\/j.anl.2017.08.005_bib0035","first-page":"582","article-title":"Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system","volume":"21","author":"Moody","year":"2000","journal-title":"Am J Otol"},{"issue":"9 Pt 1","key":"10.1016\/j.anl.2017.08.005_bib0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/000348949009900909","article-title":"Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings","volume":"99","author":"Arriaga","year":"1990","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"10.1016\/j.anl.2017.08.005_bib0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.otohns.2007.09.010","article-title":"Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies","volume":"137","author":"Moore","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.anl.2017.08.005_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10147-016-1076-8","article-title":"Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma","volume":"22","author":"Omura","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.anl.2017.08.005_bib0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00280-015-2939-9","article-title":"A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis","volume":"77","author":"Eads","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.anl.2017.08.005_bib0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.anl.2017.08.005_bib0065","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2165\/00003495-200767170-00008","article-title":"Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer","volume":"67","author":"Blick","year":"2007","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.anl.2017.08.005_bib0070","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00280-014-2462-4","article-title":"Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction","volume":"73","author":"Krens","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"10.1016\/j.anl.2017.08.005_bib0075","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hed.21057","article-title":"Cetuximab in hemodialysis: a case report","volume":"31","author":"Aldoss","year":"2009","journal-title":"Head Neck"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814617303498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814617303498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:33:59Z","timestamp":1759952039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814617303498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0385814617303498"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2017.08.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cetuximab with radiotherapy as an alternative treatment for advanced squamous cell carcinoma of the temporal bone","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}